Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lymph node metastasis as a prognostic factor in cervical carcinoma].

Juliusz Kobierski1, Janusz Emerich, Beata Królikowska

  • 1Kliniki Ginekologii Instytutu Połoznictwa i Chorób Kobiecych Akademii Medycznej w Gdańsku.

Ginekologia Polska
|May 2, 2003
PubMed
Summary

Pelvic lymph node metastasis is a significant prognostic factor for cervical cancer survival. Patients with nodal metastases have significantly worse long-term survival rates, especially without postoperative radiotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

[Micrometastases in sentinel lymph node in endometrial cancer patients].

Ginekologia polska·2015
Same author

[Chemosensitivity testing in ovarian cancer--prospects for the future].

Ginekologia polska·2014
Same author

Randomized, phase II, placebo-controlled, double-blind study with and without enzastaurin in combination with paclitaxel and carboplatin as first-line treatment followed by maintenance treatment in advanced ovarian cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2013
Same author

Preoperative detection of sentinel lymph nodes in endometrial cancer using SPECT/CT.

Clinical nuclear medicine·2013
Same author

Comparison of SPECT-CT results and intraoperative detection of sentinel lymph nodes in endometrial cancer.

Nuclear medicine communications·2013

Area of Science:

  • Gynecologic Oncology
  • Surgical Pathology
  • Clinical Prognostics

Context:

  • Cervical cancer staging and treatment decisions rely heavily on accurate assessment of lymph node involvement.
  • Radical hysterectomy with pelvic lymph node dissection is a standard surgical approach for early-stage cervical cancer.
  • Understanding patterns of lymph node metastasis is crucial for refining treatment strategies and improving patient outcomes.

Purpose:

  • To investigate the incidence and patterns of pelvic lymph node metastasis in early-stage cervical carcinoma (FIGO stages Ia, Ib, IIa).
  • To evaluate the prognostic significance of lymph node metastasis on 5-year survival rates in these patients.
  • To identify specific lymph node groups most frequently involved by metastases.

Summary:

Related Experiment Videos

  • A study of 499 patients with stage I and IIa cervical carcinoma found metastatic nodes in 26.3% of cases.
  • Metastasis rates were 0% for stage Ia, 24.6% for stage Ib, and 38.5% for stage IIa.
  • Common iliac and obturatorious nodes were the most frequent sites of metastasis. Five-year survival was 82.2% without nodal metastases versus 50.8% with metastases (p=0.005).

    • Impact:

    • Pelvic lymph node status is a critical prognostic indicator for long-term survival in cervical cancer patients.
    • The presence of lymph node metastases significantly worsens survival, particularly in patients not receiving adjuvant radiotherapy.
    • Findings support the importance of thorough pelvic lymphadenectomy and risk stratification in early-stage cervical cancer management.